These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24235143)

  • 1. Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis.
    Broege A; Pham L; Jensen ED; Emery A; Huang TH; Stemig M; Beppu H; Petryk A; O'Connor M; Mansky K; Gopalakrishnan R
    J Biol Chem; 2013 Dec; 288(52):37230-40. PubMed ID: 24235143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
    Omi M; Kaartinen V; Mishina Y
    J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro.
    Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S
    Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
    Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
    Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Morphogenetic Protein-2 Promotes Osteoclasts-mediated Osteolysis via Smad1 and p65 Signaling Pathways.
    Miao X; Yuan J; Wu J; Zheng J; Zheng W; Wang F; Wang C; Li X; Liu S; Shi Z; Li J
    Spine (Phila Pa 1976); 2021 Feb; 46(4):E234-E242. PubMed ID: 33156278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
    Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
    Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors.
    Jensen ED; Pham L; Billington CJ; Espe K; Carlson AE; Westendorf JJ; Petryk A; Gopalakrishnan R; Mansky K
    J Cell Biochem; 2010 Mar; 109(4):672-82. PubMed ID: 20039313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing effects of myricetin on the osteogenic differentiation of human periodontal ligament stem cells via BMP-2/Smad and ERK/JNK/p38 mitogen-activated protein kinase signaling pathway.
    Kim HY; Park SY; Choung SY
    Eur J Pharmacol; 2018 Sep; 834():84-91. PubMed ID: 30012495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.
    Wu X; Chim SM; Kuek V; Lim BS; Chow ST; Zhao J; Yang S; Rosen V; Tickner J; Xu J
    FEBS Lett; 2014 Jan; 588(1):143-50. PubMed ID: 24269886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoclast differentiation regulated by receptor activator of nuclear factor kappaB probably through a novel signaling pathway].
    Xu DR; Chen HZ; Wang HH; Li J; Luo SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):607-11. PubMed ID: 19549373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation.
    Pham L; Beyer K; Jensen ED; Rodriguez JS; Davydova J; Yamamoto M; Petryk A; Gopalakrishnan R; Mansky KC
    J Cell Biochem; 2011 Mar; 112(3):793-803. PubMed ID: 21328453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity.
    Jun JH; Yoon WJ; Seo SB; Woo KM; Kim GS; Ryoo HM; Baek JH
    J Biol Chem; 2010 Nov; 285(47):36410-9. PubMed ID: 20851880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression.
    Ghosh-Choudhury N; Singha PK; Woodruff K; St Clair P; Bsoul S; Werner SL; Choudhury GG
    J Biol Chem; 2006 Jul; 281(29):20160-70. PubMed ID: 16707491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad1/5 and Smad4 expression are important for osteoclast differentiation.
    Tasca A; Stemig M; Broege A; Huang B; Davydova J; Zwijsen A; Umans L; Jensen ED; Gopalakrishnan R; Mansky KC
    J Cell Biochem; 2015 Jul; 116(7):1350-60. PubMed ID: 25711193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.
    Sotillo Rodriguez JE; Mansky KC; Jensen ED; Carlson AE; Schwarz T; Pham L; MacKenzie B; Prasad H; Rohrer MD; Petryk A; Gopalakrishnan R
    J Bone Miner Res; 2009 Nov; 24(11):1917-26. PubMed ID: 19419314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.